Loading…

Inhibition of the hyperalgesic activity of Bothrops jararaca venom by an antibothropic fraction isolated from opossum ( Didelphis marsupialis) serum

The antibothropic fraction (ABF) already isolated from Didelphis marsupialis serum, inhibits the haemorrhagic, oedematogenic, myonecrotic and lethal activities of Bothrops jararaca venom (Bjv). The aim of this work was to verify the capability of ABF to inhibit the hyperalgesic activity of Bjv. Intr...

Full description

Saved in:
Bibliographic Details
Published in:Toxicon (Oxford) 2000-06, Vol.38 (6), p.875-880
Main Authors: Rocha, Surza L.G, Frutuoso, Valber S, Domont, Gilberto B, Martins, Marco A, Moussatché, Haity, Perales, Jonas
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c421t-ae62cf0db0ddc38ecac285ebd60ed1c5d4afcb833eb1fde0fa3128b165aca97e3
cites cdi_FETCH-LOGICAL-c421t-ae62cf0db0ddc38ecac285ebd60ed1c5d4afcb833eb1fde0fa3128b165aca97e3
container_end_page 880
container_issue 6
container_start_page 875
container_title Toxicon (Oxford)
container_volume 38
creator Rocha, Surza L.G
Frutuoso, Valber S
Domont, Gilberto B
Martins, Marco A
Moussatché, Haity
Perales, Jonas
description The antibothropic fraction (ABF) already isolated from Didelphis marsupialis serum, inhibits the haemorrhagic, oedematogenic, myonecrotic and lethal activities of Bothrops jararaca venom (Bjv). The aim of this work was to verify the capability of ABF to inhibit the hyperalgesic activity of Bjv. Intraplantar injection of Bjv induced hyperalgesia in a time- and dose-dependent manner and ABF administered in situ concomitantly with Bjv or i.v. 30 min before venom injection reduced the induced hyperalgesia. This same effect was observed when ABF was intravenously injected at 5 and 15 min after Bjv. Our results show that ABF inhibits also the hyperalgesia induced by Bjv.
doi_str_mv 10.1016/S0041-0101(99)00190-7
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_17508767</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0041010199001907</els_id><sourcerecordid>17508767</sourcerecordid><originalsourceid>FETCH-LOGICAL-c421t-ae62cf0db0ddc38ecac285ebd60ed1c5d4afcb833eb1fde0fa3128b165aca97e3</originalsourceid><addsrcrecordid>eNqFkc1u1TAQhS0EopfCI4C8QKhdBMbJzY9XFZS_SpVYAGvLsSdkqiQOtnOl-x48ME5zBeyQLXlkf2d8dIax5wJeCxDVm68Ae5FBqi-kvAQQErL6AduJppZZIUp4yHZ_kDP2JIQ7ACgaWT1mZwIqWco637FfN1NPLUVyE3cdjz3y_jij18MPDGS4NpEOFI_r4zsXe-_mwO-0T8tofsDJjbw9cj2lHandiKTr_KpMTSm4QUe06SahbnYhLCO_4O_J4jD3FPiofVhm0gOFSx7QL-NT9qjTQ8Bnp_Ocff_44dv15-z2y6eb67e3mdnnImYaq9x0YFuw1hQNGm3ypsTWVoBWmNLudWfapiiwFZ1F6HQh8qYVVZm8yxqLc_Zq6zt793PBENVIweAw6AndEpSoS2jqqk5guYHGJ_8eOzV7Sr6PSoBax6Hux6HWrJWU6n4catW9OH2wtCPaf1Rb_gl4eQJ0MHpIqU2Gwl-ugFxKSNjVhmFK40DoVTCEk0FLHk1U1tF_nPwGtUir2A</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>17508767</pqid></control><display><type>article</type><title>Inhibition of the hyperalgesic activity of Bothrops jararaca venom by an antibothropic fraction isolated from opossum ( Didelphis marsupialis) serum</title><source>Elsevier:Jisc Collections:Elsevier Read and Publish Agreement 2022-2024:Freedom Collection (Reading list)</source><creator>Rocha, Surza L.G ; Frutuoso, Valber S ; Domont, Gilberto B ; Martins, Marco A ; Moussatché, Haity ; Perales, Jonas</creator><creatorcontrib>Rocha, Surza L.G ; Frutuoso, Valber S ; Domont, Gilberto B ; Martins, Marco A ; Moussatché, Haity ; Perales, Jonas</creatorcontrib><description>The antibothropic fraction (ABF) already isolated from Didelphis marsupialis serum, inhibits the haemorrhagic, oedematogenic, myonecrotic and lethal activities of Bothrops jararaca venom (Bjv). The aim of this work was to verify the capability of ABF to inhibit the hyperalgesic activity of Bjv. Intraplantar injection of Bjv induced hyperalgesia in a time- and dose-dependent manner and ABF administered in situ concomitantly with Bjv or i.v. 30 min before venom injection reduced the induced hyperalgesia. This same effect was observed when ABF was intravenously injected at 5 and 15 min after Bjv. Our results show that ABF inhibits also the hyperalgesia induced by Bjv.</description><identifier>ISSN: 0041-0101</identifier><identifier>EISSN: 1879-3150</identifier><identifier>DOI: 10.1016/S0041-0101(99)00190-7</identifier><identifier>PMID: 10695972</identifier><identifier>CODEN: TOXIA6</identifier><language>eng</language><publisher>Oxford: Elsevier Ltd</publisher><subject>Animal poisons toxicology. Antivenoms ; Animals ; Anti-Inflammatory Agents - therapeutic use ; Anti-Inflammatory Agents, Non-Steroidal - therapeutic use ; Antivenins - blood ; Antivenins - therapeutic use ; Azepines - therapeutic use ; Biological and medical sciences ; Bothrops ; Bothrops jararaca ; Bothrops jararaca venom ; Crotalid Venoms - antagonists &amp; inhibitors ; Crotalid Venoms - toxicity ; Dexamethasone - therapeutic use ; Didelphis marsupialis ; Didelphis marsupialis resistance ; hyperalgesia ; Hyperalgesia - chemically induced ; Hyperalgesia - prevention &amp; control ; Hyperalgesic activity ; Indomethacin - therapeutic use ; Medical sciences ; Natural immunity ; Opossums - blood ; Platelet Aggregation Inhibitors - therapeutic use ; Toxicology ; Triazoles - therapeutic use</subject><ispartof>Toxicon (Oxford), 2000-06, Vol.38 (6), p.875-880</ispartof><rights>2000 Elsevier Science Ltd</rights><rights>2000 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c421t-ae62cf0db0ddc38ecac285ebd60ed1c5d4afcb833eb1fde0fa3128b165aca97e3</citedby><cites>FETCH-LOGICAL-c421t-ae62cf0db0ddc38ecac285ebd60ed1c5d4afcb833eb1fde0fa3128b165aca97e3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=1302990$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/10695972$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Rocha, Surza L.G</creatorcontrib><creatorcontrib>Frutuoso, Valber S</creatorcontrib><creatorcontrib>Domont, Gilberto B</creatorcontrib><creatorcontrib>Martins, Marco A</creatorcontrib><creatorcontrib>Moussatché, Haity</creatorcontrib><creatorcontrib>Perales, Jonas</creatorcontrib><title>Inhibition of the hyperalgesic activity of Bothrops jararaca venom by an antibothropic fraction isolated from opossum ( Didelphis marsupialis) serum</title><title>Toxicon (Oxford)</title><addtitle>Toxicon</addtitle><description>The antibothropic fraction (ABF) already isolated from Didelphis marsupialis serum, inhibits the haemorrhagic, oedematogenic, myonecrotic and lethal activities of Bothrops jararaca venom (Bjv). The aim of this work was to verify the capability of ABF to inhibit the hyperalgesic activity of Bjv. Intraplantar injection of Bjv induced hyperalgesia in a time- and dose-dependent manner and ABF administered in situ concomitantly with Bjv or i.v. 30 min before venom injection reduced the induced hyperalgesia. This same effect was observed when ABF was intravenously injected at 5 and 15 min after Bjv. Our results show that ABF inhibits also the hyperalgesia induced by Bjv.</description><subject>Animal poisons toxicology. Antivenoms</subject><subject>Animals</subject><subject>Anti-Inflammatory Agents - therapeutic use</subject><subject>Anti-Inflammatory Agents, Non-Steroidal - therapeutic use</subject><subject>Antivenins - blood</subject><subject>Antivenins - therapeutic use</subject><subject>Azepines - therapeutic use</subject><subject>Biological and medical sciences</subject><subject>Bothrops</subject><subject>Bothrops jararaca</subject><subject>Bothrops jararaca venom</subject><subject>Crotalid Venoms - antagonists &amp; inhibitors</subject><subject>Crotalid Venoms - toxicity</subject><subject>Dexamethasone - therapeutic use</subject><subject>Didelphis marsupialis</subject><subject>Didelphis marsupialis resistance</subject><subject>hyperalgesia</subject><subject>Hyperalgesia - chemically induced</subject><subject>Hyperalgesia - prevention &amp; control</subject><subject>Hyperalgesic activity</subject><subject>Indomethacin - therapeutic use</subject><subject>Medical sciences</subject><subject>Natural immunity</subject><subject>Opossums - blood</subject><subject>Platelet Aggregation Inhibitors - therapeutic use</subject><subject>Toxicology</subject><subject>Triazoles - therapeutic use</subject><issn>0041-0101</issn><issn>1879-3150</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2000</creationdate><recordtype>article</recordtype><recordid>eNqFkc1u1TAQhS0EopfCI4C8QKhdBMbJzY9XFZS_SpVYAGvLsSdkqiQOtnOl-x48ME5zBeyQLXlkf2d8dIax5wJeCxDVm68Ae5FBqi-kvAQQErL6AduJppZZIUp4yHZ_kDP2JIQ7ACgaWT1mZwIqWco637FfN1NPLUVyE3cdjz3y_jij18MPDGS4NpEOFI_r4zsXe-_mwO-0T8tofsDJjbw9cj2lHandiKTr_KpMTSm4QUe06SahbnYhLCO_4O_J4jD3FPiofVhm0gOFSx7QL-NT9qjTQ8Bnp_Ocff_44dv15-z2y6eb67e3mdnnImYaq9x0YFuw1hQNGm3ypsTWVoBWmNLudWfapiiwFZ1F6HQh8qYVVZm8yxqLc_Zq6zt793PBENVIweAw6AndEpSoS2jqqk5guYHGJ_8eOzV7Sr6PSoBax6Hux6HWrJWU6n4catW9OH2wtCPaf1Rb_gl4eQJ0MHpIqU2Gwl-ugFxKSNjVhmFK40DoVTCEk0FLHk1U1tF_nPwGtUir2A</recordid><startdate>20000601</startdate><enddate>20000601</enddate><creator>Rocha, Surza L.G</creator><creator>Frutuoso, Valber S</creator><creator>Domont, Gilberto B</creator><creator>Martins, Marco A</creator><creator>Moussatché, Haity</creator><creator>Perales, Jonas</creator><general>Elsevier Ltd</general><general>Elsevier Science</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7U7</scope><scope>C1K</scope></search><sort><creationdate>20000601</creationdate><title>Inhibition of the hyperalgesic activity of Bothrops jararaca venom by an antibothropic fraction isolated from opossum ( Didelphis marsupialis) serum</title><author>Rocha, Surza L.G ; Frutuoso, Valber S ; Domont, Gilberto B ; Martins, Marco A ; Moussatché, Haity ; Perales, Jonas</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c421t-ae62cf0db0ddc38ecac285ebd60ed1c5d4afcb833eb1fde0fa3128b165aca97e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2000</creationdate><topic>Animal poisons toxicology. Antivenoms</topic><topic>Animals</topic><topic>Anti-Inflammatory Agents - therapeutic use</topic><topic>Anti-Inflammatory Agents, Non-Steroidal - therapeutic use</topic><topic>Antivenins - blood</topic><topic>Antivenins - therapeutic use</topic><topic>Azepines - therapeutic use</topic><topic>Biological and medical sciences</topic><topic>Bothrops</topic><topic>Bothrops jararaca</topic><topic>Bothrops jararaca venom</topic><topic>Crotalid Venoms - antagonists &amp; inhibitors</topic><topic>Crotalid Venoms - toxicity</topic><topic>Dexamethasone - therapeutic use</topic><topic>Didelphis marsupialis</topic><topic>Didelphis marsupialis resistance</topic><topic>hyperalgesia</topic><topic>Hyperalgesia - chemically induced</topic><topic>Hyperalgesia - prevention &amp; control</topic><topic>Hyperalgesic activity</topic><topic>Indomethacin - therapeutic use</topic><topic>Medical sciences</topic><topic>Natural immunity</topic><topic>Opossums - blood</topic><topic>Platelet Aggregation Inhibitors - therapeutic use</topic><topic>Toxicology</topic><topic>Triazoles - therapeutic use</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Rocha, Surza L.G</creatorcontrib><creatorcontrib>Frutuoso, Valber S</creatorcontrib><creatorcontrib>Domont, Gilberto B</creatorcontrib><creatorcontrib>Martins, Marco A</creatorcontrib><creatorcontrib>Moussatché, Haity</creatorcontrib><creatorcontrib>Perales, Jonas</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Toxicology Abstracts</collection><collection>Environmental Sciences and Pollution Management</collection><jtitle>Toxicon (Oxford)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Rocha, Surza L.G</au><au>Frutuoso, Valber S</au><au>Domont, Gilberto B</au><au>Martins, Marco A</au><au>Moussatché, Haity</au><au>Perales, Jonas</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Inhibition of the hyperalgesic activity of Bothrops jararaca venom by an antibothropic fraction isolated from opossum ( Didelphis marsupialis) serum</atitle><jtitle>Toxicon (Oxford)</jtitle><addtitle>Toxicon</addtitle><date>2000-06-01</date><risdate>2000</risdate><volume>38</volume><issue>6</issue><spage>875</spage><epage>880</epage><pages>875-880</pages><issn>0041-0101</issn><eissn>1879-3150</eissn><coden>TOXIA6</coden><abstract>The antibothropic fraction (ABF) already isolated from Didelphis marsupialis serum, inhibits the haemorrhagic, oedematogenic, myonecrotic and lethal activities of Bothrops jararaca venom (Bjv). The aim of this work was to verify the capability of ABF to inhibit the hyperalgesic activity of Bjv. Intraplantar injection of Bjv induced hyperalgesia in a time- and dose-dependent manner and ABF administered in situ concomitantly with Bjv or i.v. 30 min before venom injection reduced the induced hyperalgesia. This same effect was observed when ABF was intravenously injected at 5 and 15 min after Bjv. Our results show that ABF inhibits also the hyperalgesia induced by Bjv.</abstract><cop>Oxford</cop><pub>Elsevier Ltd</pub><pmid>10695972</pmid><doi>10.1016/S0041-0101(99)00190-7</doi><tpages>6</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0041-0101
ispartof Toxicon (Oxford), 2000-06, Vol.38 (6), p.875-880
issn 0041-0101
1879-3150
language eng
recordid cdi_proquest_miscellaneous_17508767
source Elsevier:Jisc Collections:Elsevier Read and Publish Agreement 2022-2024:Freedom Collection (Reading list)
subjects Animal poisons toxicology. Antivenoms
Animals
Anti-Inflammatory Agents - therapeutic use
Anti-Inflammatory Agents, Non-Steroidal - therapeutic use
Antivenins - blood
Antivenins - therapeutic use
Azepines - therapeutic use
Biological and medical sciences
Bothrops
Bothrops jararaca
Bothrops jararaca venom
Crotalid Venoms - antagonists & inhibitors
Crotalid Venoms - toxicity
Dexamethasone - therapeutic use
Didelphis marsupialis
Didelphis marsupialis resistance
hyperalgesia
Hyperalgesia - chemically induced
Hyperalgesia - prevention & control
Hyperalgesic activity
Indomethacin - therapeutic use
Medical sciences
Natural immunity
Opossums - blood
Platelet Aggregation Inhibitors - therapeutic use
Toxicology
Triazoles - therapeutic use
title Inhibition of the hyperalgesic activity of Bothrops jararaca venom by an antibothropic fraction isolated from opossum ( Didelphis marsupialis) serum
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-29T14%3A38%3A47IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Inhibition%20of%20the%20hyperalgesic%20activity%20of%20Bothrops%20jararaca%20venom%20by%20an%20antibothropic%20fraction%20isolated%20from%20opossum%20(%20Didelphis%20marsupialis)%20serum&rft.jtitle=Toxicon%20(Oxford)&rft.au=Rocha,%20Surza%20L.G&rft.date=2000-06-01&rft.volume=38&rft.issue=6&rft.spage=875&rft.epage=880&rft.pages=875-880&rft.issn=0041-0101&rft.eissn=1879-3150&rft.coden=TOXIA6&rft_id=info:doi/10.1016/S0041-0101(99)00190-7&rft_dat=%3Cproquest_cross%3E17508767%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c421t-ae62cf0db0ddc38ecac285ebd60ed1c5d4afcb833eb1fde0fa3128b165aca97e3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=17508767&rft_id=info:pmid/10695972&rfr_iscdi=true